A new study released earlier this month has shaken what the traditional medical community believes about heart health.
Worldwide, more than 500,000 heart patients are given stents annually to relieve chest pain. According to findings published in the prestigious medical journal the Lancet, these invasive heart stents may not actually reduce chest pain.
This procedure has its place in emergency situations like heart attacks. These stents, or little permanent wire cages, open up blocked arteries and can be a lifesaving way to remedy blocked arteries. Unfortunately, the majority of heart stents are inserted to relieve chest pain, according to The New York Times article, ‘Unbelievable’: Heart Stents Fail to Ease Chest Pain. The article also cited that common risks of this invasive procedure often includes death, and cautions that stents should be reserved for those facing heart attacks.
This study tested 200 participants experiencing chest pain significant enough to impact physical performance. All participants underwent the same before and after medication and therapy. All participants also thought they received a heart stent, but only half actually did. Six weeks later, researchers found no real difference in the way participants felt or in their ability to exercise.
Where’s the disconnect?
Sadly, heart stents are another example of how mainstream medicine has accepted misplaced treatments as the medical norm to ‘improve’ heart health. This shocking study rocked mainstream perspectives.
Over the past 75 years, hundreds of research studies have shown that bypass surgery and the “balloon” angioplasty procedure have failed to live up to their promise of easy success. For example, with regard to bypass surgery, angina heart pains recur in up to 20 per cent of patients during their first post-operative year and then in an additional 4 per cent for each year thereafter. A second bypass, or balloon procedure, is required in over 30 per cent of patients by 12 years after initial surgery. Re-operation carries a higher death rate and risk of heart attack associated with surgery, along with less complete relief of chest pain.
During the first year after surgery, up to two-thirds of surviving patients can suffer with heart attack, stroke, heart rhythm disturbance, worsening high blood pressure, congestive heart failure, or “pump syndrome” where their personality or mental functions change as a result of being on the heart-lung pump during a heart artery bypass operation.
Answers Can Be Found In Chelation Therapy
In the experience of many experts, EDTA chelation therapy has been overlooked for decades as the best, non-invasive heart health treatment. When done
before surgery, chelation therapy appears to reduce the need for and the risks of such operations for many patients proposed for surgery and invasive procedures. When done
after surgery, EDTA chelation appears to help maintain open arteries with fewer complications, such as heart attack or re-operation, for subsequent months and years. (Pictured left: EDTA Molecule used in chelation therapy to remove heavy metals).
The explanation starts with the role of “free radicals” in your blood. These are oxidizing molecules that look to steal an electron from (i.e. to “oxidize”) another molecule, often creating such serious damage that the “donor molecule” will no longer function. Anti-oxidants, such as vitamins C and E, beta-carotene, and bioflavonoids from foods and internally-produced glutathione, help to protect fragile cell structures from damage caused by oxidizing free radicals. Free radicals cause and amplify all human illness and injury (Journal of the American College of Toxicology, 1983).
Don’t Stop Now
In “Critical Issues To Save Your Heart” by John Parks Trowbridge MD’s book, Dr. Trowbridge explains in-depth the role of chelation therapy and how it is saving the lives of not only his patients but thousands of people across the country. This non-invasive therapy has been used for decades, restoring health avoiding both surgeries and risky procedures like heart stents.
References:
Demopoulos HB, Pietronigro DD, Seligman ML. The development of secondary pathology with free radical reactions as a threshold mechanism. Journal of the American College of Toxicology 1983;2(3):173-184.
Kolata, G. “‘Unbelievable’: Heart Stents Fail to Ease Chest Pain.” The New York Times. (2017, Nov 2017).
